Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

View

Video  •  Webinar

Webinar: In Vitro Antibody Discovery and the Potential Value of AI: The AIntibody Challenge

View

Video

HT-SPR Technology as a Data Engine for AI-Driven Drug Design

View

Video  •  Webinar

Webinar: Innovative Methods Advancing Discovery and Characterization of Antibodies

View

Video  •  Webinar

Using AI in medical research with Carterra’s LSA platform at Absci

View

Video  •  Webinar

Selectivity and Cooperativity of PROTAC®s using HT-SPR

View

Video  •  Webinar

Webinar: Massively Parallel SPR Based Fragment Screening on Ligand Arrays

View

Webinar

Changing Antibody Discovery through Lab Automation Q&A

View

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

View

Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

View

Peer-Reviewed Publication

Nature: Multivalency Transforms SARS-CoV-2 Antibodies into Ultrapotent Neutralizers

View

Peer-Reviewed Publication

Nature Medicine: A candidate antibody drug for prevention of malaria

View

Peer-Reviewed Publication

Nature Scientific Reports: High‑throughput analysis system of interaction kinetics for data‑driven antibody design

View

Peer-Reviewed Publication

Nature: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

View